The second day of what at times appeared to provide catharsis for prospective jurors against pharmaceutical executive Martin Shkreli ended on Tuesday without a jury in the securities fraud case.
More than 130 potential jurors were dismissed on Monday, many saying they could not serve because of work commitments and medical reasons. But some were bounced after saying they could not be impartial in a trial for the so-called Pharma bro and seemed to use the proceedings to vent their feelings about the pharmaceutical industry, big business generally or Shkreli specifically.
